James Crowley: Fibrosis Can Be Caused by Mechanical Disruption of the Lymphatic Vessels Alone
James Crowley, Professor of Medicine Emeritus at Brown University, Captain at U.S. Navy Reserve, shared a post on LinkedIn about a recent article by Hailey M. Shepherd et al, adding:
“Authors Kreisel and Shepherd from WashU emphasized that the research team conducted these transplants among genetically identical mice, whose tissues could not generate an immune response against one another.
This provides evidence that the fibrosis is independent of immunity against foreign tissues and instead can be caused by the mechanical disruption of the lymphatic vessels alone.
The treatment that blocked the protein responsible for manufacturing hyaluronan is called 4-methylumbelliferone (4-MU).
It is approved for use in Europe and Asia to treat biliary disorders, conditions that affect the gallbladder.
According to the researchers, it has an excellent safety profile and is therefore a promising potential route to evaluating this approach in transplant patients.”
Title: Lymphatic disruption drives lung transplant fibrosis through interleukin-1–mediated hyaluronan accumulation
Authors: Hailey M. Shepherd, Wenjun Li, Benjamin J. Kopecky, Yuriko Terada, Charles R. Liu, Zhiyi Liu, Daniel D. Lee, Katsutaka Mineura, Hao Dun, Yuhei Yokoyama, Brian W. Wong, Gokalp K. Kurtoglu, Junedh M. Amrute, Davide Scozzi, Yun Zhu Bai, Amit I. Bery, Cory T. Bernadt, Jon H. Ritter, Steven L. Brody, Derek E. Byers, Alexander S. Krupnick, Ruben G. Nava, G. Alexander Patterson, Varun Puri, Andrew E. Gelman, Kory J. Lavine, Gwendalyn J. Randolph, Daniel Kreisel
Read the Full Article on Science
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism